vs

Side-by-side financial comparison of WORKIVA INC (WK) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

WORKIVA INC is the larger business by last-quarter revenue ($238.9M vs $127.1M, roughly 1.9× Zai Lab Ltd). On growth, WORKIVA INC posted the faster year-over-year revenue change (19.5% vs 17.1%). WORKIVA INC produced more free cash flow last quarter ($50.7M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 16.6%).

Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

WK vs ZLAB — Head-to-Head

Bigger by revenue
WK
WK
1.9× larger
WK
$238.9M
$127.1M
ZLAB
Growing faster (revenue YoY)
WK
WK
+2.4% gap
WK
19.5%
17.1%
ZLAB
More free cash flow
WK
WK
$77.4M more FCF
WK
$50.7M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
16.6%
WK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
WK
WK
ZLAB
ZLAB
Revenue
$238.9M
$127.1M
Net Profit
$11.8M
Gross Margin
80.7%
51.0%
Operating Margin
3.3%
-54.6%
Net Margin
4.9%
Revenue YoY
19.5%
17.1%
Net Profit YoY
234.0%
EPS (diluted)
$0.21
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
WK
WK
ZLAB
ZLAB
Q4 25
$238.9M
$127.1M
Q3 25
$224.2M
$115.4M
Q2 25
$215.2M
$109.1M
Q1 25
$206.3M
$105.7M
Q4 24
$199.9M
$108.5M
Q3 24
$185.6M
$101.8M
Q2 24
$177.5M
$100.1M
Q1 24
$175.7M
$87.1M
Net Profit
WK
WK
ZLAB
ZLAB
Q4 25
$11.8M
Q3 25
$2.8M
$-36.0M
Q2 25
$-19.4M
$-40.7M
Q1 25
$-21.4M
$-48.4M
Q4 24
$-8.8M
Q3 24
$-17.0M
$-41.7M
Q2 24
$-17.5M
$-80.3M
Q1 24
$-11.7M
$-53.5M
Gross Margin
WK
WK
ZLAB
ZLAB
Q4 25
80.7%
51.0%
Q3 25
79.3%
59.5%
Q2 25
77.0%
60.6%
Q1 25
76.6%
63.6%
Q4 24
77.1%
61.5%
Q3 24
76.5%
64.1%
Q2 24
76.8%
64.9%
Q1 24
76.4%
61.4%
Operating Margin
WK
WK
ZLAB
ZLAB
Q4 25
3.3%
-54.6%
Q3 25
-1.5%
-42.3%
Q2 25
-10.3%
-50.3%
Q1 25
-12.0%
-53.3%
Q4 24
-6.7%
-62.6%
Q3 24
-11.7%
-66.6%
Q2 24
-13.0%
-76.0%
Q1 24
-10.4%
-80.7%
Net Margin
WK
WK
ZLAB
ZLAB
Q4 25
4.9%
Q3 25
1.2%
-31.2%
Q2 25
-9.0%
-37.3%
Q1 25
-10.4%
-45.8%
Q4 24
-4.4%
Q3 24
-9.2%
-40.9%
Q2 24
-9.9%
-80.2%
Q1 24
-6.7%
-61.4%
EPS (diluted)
WK
WK
ZLAB
ZLAB
Q4 25
$0.21
$-0.05
Q3 25
$0.05
$-0.03
Q2 25
$-0.35
$-0.04
Q1 25
$-0.38
$-0.04
Q4 24
$-0.15
$-0.09
Q3 24
$-0.31
$-0.04
Q2 24
$-0.32
$-0.08
Q1 24
$-0.21
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
WK
WK
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$338.8M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-5.4M
$715.5M
Total Assets
$1.5B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
WK
WK
ZLAB
ZLAB
Q4 25
$338.8M
$689.6M
Q3 25
$315.9M
$717.2M
Q2 25
$284.3M
$732.2M
Q1 25
$242.0M
$757.3M
Q4 24
$301.8M
$779.7M
Q3 24
$248.2M
$616.1M
Q2 24
$267.9M
$630.0M
Q1 24
$296.1M
$650.8M
Stockholders' Equity
WK
WK
ZLAB
ZLAB
Q4 25
$-5.4M
$715.5M
Q3 25
$-36.9M
$759.9M
Q2 25
$-66.5M
$791.7M
Q1 25
$-75.7M
$810.8M
Q4 24
$-41.7M
$840.9M
Q3 24
$-50.8M
$667.7M
Q2 24
$-77.7M
$704.2M
Q1 24
$-83.2M
$762.2M
Total Assets
WK
WK
ZLAB
ZLAB
Q4 25
$1.5B
$1.2B
Q3 25
$1.4B
$1.2B
Q2 25
$1.3B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.4B
$1.2B
Q3 24
$1.3B
$985.3M
Q2 24
$1.2B
$987.4M
Q1 24
$1.2B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
WK
WK
ZLAB
ZLAB
Operating Cash FlowLast quarter
$51.0M
$-26.0M
Free Cash FlowOCF − Capex
$50.7M
$-26.7M
FCF MarginFCF / Revenue
21.2%
-21.0%
Capex IntensityCapex / Revenue
0.1%
0.5%
Cash ConversionOCF / Net Profit
4.31×
TTM Free Cash FlowTrailing 4 quarters
$138.0M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
WK
WK
ZLAB
ZLAB
Q4 25
$51.0M
$-26.0M
Q3 25
$46.2M
$-32.0M
Q2 25
$50.3M
$-31.0M
Q1 25
$-7.4M
$-61.7M
Q4 24
$44.0M
$-55.8M
Q3 24
$18.9M
$-26.8M
Q2 24
$-14.0K
$-42.2M
Q1 24
$24.8M
$-90.1M
Free Cash Flow
WK
WK
ZLAB
ZLAB
Q4 25
$50.7M
$-26.7M
Q3 25
$46.1M
$-35.0M
Q2 25
$49.3M
$-33.9M
Q1 25
$-8.1M
$-63.2M
Q4 24
$43.2M
$-58.4M
Q3 24
$18.7M
$-28.2M
Q2 24
$-122.0K
$-42.9M
Q1 24
$24.6M
$-91.1M
FCF Margin
WK
WK
ZLAB
ZLAB
Q4 25
21.2%
-21.0%
Q3 25
20.5%
-30.4%
Q2 25
22.9%
-31.1%
Q1 25
-3.9%
-59.9%
Q4 24
21.6%
-53.8%
Q3 24
10.1%
-27.7%
Q2 24
-0.1%
-42.9%
Q1 24
14.0%
-104.5%
Capex Intensity
WK
WK
ZLAB
ZLAB
Q4 25
0.1%
0.5%
Q3 25
0.0%
2.6%
Q2 25
0.5%
2.6%
Q1 25
0.4%
1.5%
Q4 24
0.4%
2.4%
Q3 24
0.1%
1.3%
Q2 24
0.1%
0.7%
Q1 24
0.1%
1.1%
Cash Conversion
WK
WK
ZLAB
ZLAB
Q4 25
4.31×
Q3 25
16.57×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

WK
WK

License And Service$219.3M92%
XBRL Professional Services$16.4M7%
Other Services$3.2M1%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons